| 摘要 |
Novel oxazolidin-2-ones of the general formula I <IMAGE> in which X represents Cl, Br, I or OR<1>, R<1> represents H, alkenyl, alkynyl, alkoxyalkyl or alkenyloxyalkyl having in each case 2-6 C atoms or cycloalkyl having 3-8 C atoms and R<2> represents alkyl or hydroxyalkyl having in each case 1-6 C atoms, cycloalkyl having 3-8 C atoms, unsubstituted aralkyl, or aralkyl which is mono- to trisubstituted in the aryl moiety by alkyl, alkoxy, OH and/or Cl or monosubstituted by methylenedioxy, in each case having a total of 7-15 C atoms, are suitable for combating cardiac diseases and as intermediates. |
